Fonte: The FASEB Journal. Unidades: FM, ICB
Assuntos: IMUNOLOGIA, ACETILCOLINA, INFLAMAÇÃO, ALCALOIDES, FÁRMACOS (SISTEMA NERVOSO CENTRAL), CAMUNDONGOS, METALOPROTEINASES, CITOCINAS, MACRÓFAGOS, DOENÇAS RESPIRATÓRIAS
ABNT
PINHEIRO, Nathalia M. et al. Acute lung injury is reduced by the α7nAChR agonist PNU-282987 through changes in the macrophage profile. The FASEB Journal, v. 31, n. 1, p. 320-332, 2017Tradução . . Disponível em: https://doi.org/10.1096/fj.201600431r. Acesso em: 19 nov. 2024.APA
Pinheiro, N. M., Santana, F. P. R., Almeida, R. R., Guerreiro, M., Martins, M. de A., Caperuto, L. C., et al. (2017). Acute lung injury is reduced by the α7nAChR agonist PNU-282987 through changes in the macrophage profile. The FASEB Journal, 31( 1), 320-332. doi:10.1096/fj.201600431rNLM
Pinheiro NM, Santana FPR, Almeida RR, Guerreiro M, Martins M de A, Caperuto LC, Câmara NOS, Wensing LA, Prado VF, Tibério I de FLC, Prado MAM, Prado CM. Acute lung injury is reduced by the α7nAChR agonist PNU-282987 through changes in the macrophage profile [Internet]. The FASEB Journal. 2017 ; 31( 1): 320-332.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1096/fj.201600431rVancouver
Pinheiro NM, Santana FPR, Almeida RR, Guerreiro M, Martins M de A, Caperuto LC, Câmara NOS, Wensing LA, Prado VF, Tibério I de FLC, Prado MAM, Prado CM. Acute lung injury is reduced by the α7nAChR agonist PNU-282987 through changes in the macrophage profile [Internet]. The FASEB Journal. 2017 ; 31( 1): 320-332.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1096/fj.201600431r